Prosthetic Heart Valve Market To Surpass US$ 21,968.6 Million By 2027

1. PROSTHETIC HEART VALVE MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Prosthetic Heart Valves Market - Overview Global Prosthetic Heart Valves Market In general, bioprosthetic valves are composed of animal tissues that are mounted on a metal or polymer support. These valves are harvested from the cow heart sac (bovine) or porcine (pig’s) heart valves. The less invasive procedure to replace the damaged aortic valve with bioprosthetic aortic valve is the percutaneous aortic valve replacement (PAVR). Transcatheter mitral valve repair is a minimally invasive procedure for the treatment of degenerative mitral regurgitation (MR) disorder, mostly affecting the ageing population. The global prosthetic heart valves market is estimated to garner up to US$ 21,968.6 million, in terms of value, by the end of 2027. Increasing heart valve implantation procedures to bolster the global market expansion Rising number of heart valve implantation procedures being performed globally is expected to propel the growth of the global prosthetic heart valves market over the forecast period. For instance, in the study titled ‘Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections’, published in the European Heart Journal in July 2018, it was estimated that 114,757 and 58,556 candidates get transcatheter aortic valve implantation done in Europe and Northern America respectively, each year. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/prosthetic-heart-valve-market-69 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Mechanical heart valves are the most commonly used prosthetic heart valves in the treatment of patients with a valvular heart disease. These valves are highly durable and bring out favorable outcomes on usage, as compared to tissue heart valves. However, tissue heart valves are more preferable for the treatment of geriatric patients, as these are accepted much faster by the body. Therefore, numerous companies are working on the improvement of tissue heart valve (bioprosthetic valve) implantation products, in order to expand their lifespan, and thus increase their adoption. In contrast, increasing product recalls is predicted to hamper the growth of the global prosthetic heart valves market in the near future. For instance, in August 2019, Edwards Lifesciences recalled its Sapien 3 Ultra replacement heart valve amid risk of bursting of balloons during the implantation of the transcatheter aortic valve. Key Market Takeaways The biological/tissue heart valves segment held the foremost position in the global prosthetic heart valves market in 2019, accounting for an impressive 42.0% share, in terms of value. Increasing heart valve implantation procedures is expected to fuel the demand for prosthetic heart valves over the forecast timeframe. Moreover, the transcatheter heart valves segment in the global prosthetic heart valves market was valued at US$ 2,572.8 million in 2019 and is expected to reach US$ 6,874.8 million over the projected period, displaying a CAGR of 13.1%. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/69 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION The prevalence rate of congenital heart disease has been found to be high among children, especially in the developing nations, which in turn, fosters the demand for prosthetic heart valves worldwide. According to a study, titled ‘Prevalence, profile, and pattern of congenital heart disease in Central India: A prospective, observational study’, published in May 2018, the prevalence rate of congenital heart disease was valued at 10.13/1000 live births. Competitive Landscape The major players operating in the global prosthetic heart valves market include Edwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve, LLC, and JenaValve Technology, Inc. Key Developments In September 2019, Medtronic Plc launched the Evolut PRO+ TAVR System, which is a new- generation TAVR system intended for the treatment of patients with symptomatic severe aortic stenosis, who are at a low risk of surgical mortality. Furthermroe, in February 2019, LivaNova PLC received reimbursement for its Perceval sutureless aortic heart valve in Japan from the Ministry of Health, Labor and Welfare, for the treatment of the aortic valve disease. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/69 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved